feed,title,long_url,short_url
Yahoo,Sarepta stock rises after FDA approves biotech's Duchenne MD treatment,https://www.marketwatch.com/story/sarepta-stock-rises-after-fda-approves-biotechs-duchenne-md-treatment-2021-02-25?siteid=yhoof2&yptr=yahoo,https://on.mktw.net/3pVRfH2
